Johnson & Johnson signed a $456.2 million deal to develop a COVID-19 vaccine and a $148.4 million deal to develop antiviral therapies.
Moderna also was awarded a $483 million deal to develop a COVID-19 vaccine.
Other companies have secured nine-figure deals for medical supplies, including ventilators and N95 face masks, Bloomberg Law reported.
The top 20 recipients of U.S. COVID-19 contracting dollars and what they were contracted for:
- Royal Philips — ventilators
- Johnson & Johnson — vaccine
- Hamilton Medical — ventilators
- Moderna — vaccine
- Vyaire Holding — ventilators
- GE — ventilators
- Asahi Kasei — ventilators
- RER Financial Group — SBA analysis
- Dell Technologies — computers
- 3M — N95 masks
- Honeywell — N95 masks
- ACS — NY Care Facility
- Global Medical Response — transport
- Aecom — NY Care Facility
- Airboss of America — respirators
- Regeneron — drug development
- FedEx — shipping
- Panthera Worldwide — N95 masks
- Mitchell International — ventilators
- Colossal Contracting — computers
Read the full article here.
More articles on pharmacy:
Largest hydroxychloroquine study to date finds no benefit for COVID-19
NIH panel releases COVID-19 treatment, pharmaceutical intervention guidelines
How 13 drugmakers have responded to the COVID-19 pandemic
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
